RI

Rajeswari Isanaka

Director Additional Director DIN 02222521
DIN 02222521 First appointment Sep 2004 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2004
Shareholding value •••• Premium profile

About Rajeswari Isanaka

Data last updated:

Rajeswari Isanaka was an Additional Director at Issar Investments (India) Private Limited (2015–2022) and Director at Issar Pharmaceuticals Private Limited (2004–2015). The companies operate in Financial Services and Pharma.

DIN 02222521
Primary Designation Additional Director
Industry Financial Services
First Appointment 01 Sep 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director03 Aug 20152011₹49.2 Lakh (FY 2023)Under Liquidation
Director01 Sep 20041995₹8.31 Cr (FY 2024)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Issar Investments (India) Private Limited
Issar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajeswari Isanaka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeswari Isanaka

Rajeswari Isanaka was first appointed on 01 Sep 2004 as Director at Issar Pharmaceuticals Private Limited. The most recent appointment on record is 03 Aug 2015 at Issar Investments (India) Private Limited.

Rajeswari Isanaka held 2 earlier board appointments: Issar Investments (India) Private Limited (Additional Director, 03 Aug 2015 to 12 Jan 2022); Issar Pharmaceuticals Private Limited (Director, 01 Sep 2004 to 26 Nov 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available